United Therapeutics Corporation (UTHR) Insider Trading

Total insider buys:
  • $999,400.80
Total insider sells:
  • $831,715,183.10
Most recent insider trade:
  • April 14, 2025
Most active insider trader:
  • Martine A Rothblatt
Trader NameDateTitleAmountPriceTypeTotal Value
Jan. 2, 2014Director3,000$111.41Sell$334,230.00
Jan. 2, 2014CEO3,833$111.54Sell$427,532.82
Dec. 31, 2013CEO18,140$112.64Sell$2,043,289.60
Dec. 30, 2013CEO18,147$111.60Sell$2,025,205.20
Dec. 27, 2013CEO18,147$113.15Sell$2,053,333.05
Dec. 26, 2013CEO21,981$111.95Sell$2,460,772.95
Dec. 24, 2013CEO18,149$114.05Sell$2,069,893.45
Dec. 23, 2013CEO5,743$109.71Sell$630,064.53
Dec. 20, 2013CEO18,149$86.72Sell$1,573,881.28
Dec. 20, 2013COO8,250$87.84Sell$724,680.00
Dec. 19, 2013EVP6,000$86.45Sell$518,700.00
Dec. 19, 2013CEO21,982$86.73Sell$1,906,498.86
Dec. 18, 2013CEO18,149$86.36Sell$1,567,347.64
Dec. 17, 2013CEO12,251$86.49Sell$1,059,588.99
Dec. 6, 2013COO10,000$90.97Sell$909,700.00
Dec. 5, 2013Director3,000$90.13Sell$270,390.00
Dec. 5, 2013EVP6,000$89.18Sell$535,080.00
Dec. 5, 2013CEO3,833$89.79Sell$344,165.07
Nov. 21, 2013CEO3,833$92.49Sell$354,514.17
Nov. 21, 2013EVP6,000$92.47Sell$554,820.00
Nov. 15, 2013COO10,000$94.00Sell$940,000.00
Nov. 14, 2013Director5,500$91.65Sell$504,075.00
Nov. 14, 2013CEO3,833$91.60Sell$351,102.80
Nov. 7, 2013EVP6,000$89.60Sell$537,600.00
Nov. 7, 2013CEO3,833$89.47Sell$342,938.51
Nov. 7, 2013Director3,500$90.51Sell$316,785.00
Nov. 1, 2013Director3,000$89.18Sell$267,540.00
Nov. 1, 2013COO10,000$90.34Sell$903,400.00
Oct. 31, 2013CEO3,833$86.89Sell$333,049.37
Oct. 24, 2013CEO3,833$83.77Sell$321,090.41
Oct. 18, 2013COO10,000$82.47Sell$824,700.00
Oct. 17, 2013EVP6,000$81.79Sell$490,740.00
Oct. 17, 2013CFO2,750$82.01Sell$225,527.50
Oct. 17, 2013CEO3,833$81.84Sell$313,692.72
Oct. 10, 2013CEO3,833$82.58Sell$316,529.14
Oct. 4, 2013COO10,000$85.48Sell$854,800.00
Oct. 3, 2013Director1,500$83.15Sell$124,725.00
Oct. 3, 2013CFO4,500$84.67Sell$381,015.00
Oct. 3, 2013CEO3,833$84.20Sell$322,738.60
Oct. 3, 2013EVP6,000$84.38Sell$506,280.00
Sept. 26, 2013CEO3,833$78.41Sell$300,545.53
Sept. 20, 2013COO10,000$77.86Sell$778,600.00
Sept. 19, 2013CFO4,500$78.67Sell$354,015.00
Sept. 19, 2013EVP6,000$78.02Sell$468,120.00
Sept. 19, 2013CEO3,833$78.12Sell$299,433.96
Sept. 12, 2013CEO3,833$76.98Sell$295,064.34
Sept. 6, 2013COO10,000$73.67Sell$736,700.00
Sept. 5, 2013CEO3,833$73.63Sell$282,223.79
Sept. 5, 2013EVP6,000$73.29Sell$439,740.00
Sept. 5, 2013CFO4,500$74.17Sell$333,765.00
  • Insiders are both buying and selling United Therapeutics Corporation stock.

  • The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, Raymond Dwek, John Maxim Ferrari, Christopher Patusky, Paul Mahon, David Zaccardelli, Michael Benkowitz, Richard Giltner, Nilda Mesa, James Edgemond, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Ray Kurzweil, Paul A. Mahon, Judy D. Olian, R Paul Gray, MAHON PAUL A, Louis Sullivan, Tommy G. Thompson, and DWEK RAYMOND

  • The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.

  • Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.

  • Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.

  • The most recent insider trade for United Therapeutics Corporation was on April 14, 2025.

  • The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.

  • The single biggest insider sell for United Therapeutics Corporation was from Louis W Sullivan with a total value of $9,781,722.98 on Dec. 18, 2024.